scholarly journals CIC-DUX4 rearranged uterine cervix round-cell sarcoma exhibiting near-complete pathologic response following radiation and neoadjuvant chemotherapy: A case report

2021 ◽  
Vol 36 ◽  
pp. 100745
Author(s):  
Aline Cristini Vieira ◽  
Camila Bragança Xavier ◽  
Thiago Dieb Vieira ◽  
Filomena Marino Carvalho ◽  
Mariana Scaranti ◽  
...  
2019 ◽  
Vol 12 (2) ◽  
pp. 631-638 ◽  
Author(s):  
Maylis Guizard ◽  
Marie Karanian ◽  
Frédérique Dijoud ◽  
Amine Bouhamama ◽  
Cécile Faure-Conter ◽  
...  

Neonatal soft tissues sarcoma is a rare entity that comprises heterogeneous types of tumors. In this article we describe a neonatal case of round-cell sarcoma with an YWHAE-NUTM2B fusion gene. The patient was treated just after birth with neoadjuvant chemotherapy, then surgical resection, but evolution was quickly fatal. This fusion transcript has been reported in endometrial stromal sarcomas and clear cells renal sarcomas but its description in small round-cell sarcomas is recent. To our knowledge, this is the first case report describing this translocation in a newborn patient with soft tissues sarcoma and its clinical tumoral evolution.


Breast Care ◽  
2013 ◽  
Vol 8 (1) ◽  
pp. 74-76 ◽  
Author(s):  
Alberto Alvarado-Miranda ◽  
Ludwing Bacon-Fonseca ◽  
Ulises Lara-Medina Fernando ◽  
Hector Maldonado-Martínez ◽  
Claudia Arce-Salinas

2018 ◽  
Vol 14 (9) ◽  
pp. 569-571 ◽  
Author(s):  
Addie Hill ◽  
Jun Gong ◽  
Sharon Wilczynski ◽  
Rizvan Mirza ◽  
Loretta Erhunmwunsee ◽  
...  

2021 ◽  
Vol 2021 (4) ◽  
Author(s):  
Jacqueline B Baikovitz ◽  
Lindsay Thornton ◽  
Monica T Garcia-Buitrago ◽  
Alan S Livingstone ◽  
Matthew T Studenski ◽  
...  

Abstract Yttrium-90 (Y-90) trans-arterial radioembolization (TARE) is used in the management of unresectable hepatocellular carcinoma (HCC). During the last 5 years, dosimetry software has been developed to allow for a more rigorous approach of dose prescription in Y-90 TARE. We present here a case study of a 77-year-old woman diagnosed with HCC, who underwent a Y-90 TARE as a bridge procedure to liver resection. This clinical scenario represents a unique opportunity to illustrate the predictive value of dosimetric findings correlating dosimetry with pathological findings. In this case, Y-90 TARE dosimetry was predictive of treatment response in which the tumor received a mean dose of 156 Gy and demonstrated a complete pathologic response.


2016 ◽  
Vol 14 (1) ◽  
pp. e59-e65 ◽  
Author(s):  
Venkata K. Pokuri ◽  
Johar R. Syed ◽  
Zhengyu Yang ◽  
Erinn P. Field ◽  
Susanna Cyriac ◽  
...  

2021 ◽  
Vol Volume 14 ◽  
pp. 4537-4544
Author(s):  
Jiao Zhu ◽  
Bo Li ◽  
Juan Juan Hu ◽  
Weiping Liu ◽  
Dan Lu ◽  
...  

Cancer ◽  
2006 ◽  
Vol 107 (6) ◽  
pp. 1248-1254 ◽  
Author(s):  
Florentia Peintinger ◽  
W. Fraser Symmans ◽  
Ana M. Gonzalez-Angulo ◽  
Judy C. Boughey ◽  
Aman U. Buzdar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document